Literature DB >> 18288940

AKT signaling in regulating angiogenesis.

Bing-Hua Jiang1, Ling-Zhi Liu.   

Abstract

AKT is a central signaling molecule in regulating cell survival, proliferation, tumor growth and angiogenesis. Upstream components of AKT signaling pathway such as PI3K, PTEN, and Ras are commonly mutated in many human cancers. Recently it is found that AKT plays an important role in regulating normal vascularization and pathological angiogenesis. Angiogenesis is required for tumor growth and metastasis when tumor reaches more than 1 mm in diameter. This review focuses on the role and potential mechanism of AKT signaling in regulating angiogenesis. Recent studies have shown that AKT activation is necessary and sufficient to regulate VEGF and HIF-1 expression in human cancer cells. VEGF and HIF-1 are potent inducers of angiogenesis. It was found that AKT activation induces VEGF and HIF-1 expression through its two downstream molecules HDM2 and p70S6K1. On the other hand, AKT transmits the upstream signals from growth factors, cytokines, heavy metals, and oncogenes for regulating VEGF and HIF-1 expression in human cancer cells. AKT activation and VEGF expression can be inhibited by different natural compounds used for cancer prevention. Thus, inhibition of AKT and its downstream targets offers a new approach for targeting angiogenesis, which could be important for the development of new cancer therapeutics in the future.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18288940     DOI: 10.2174/156800908783497122

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  73 in total

1.  IL-17 contributes to angiogenesis in rheumatoid arthritis.

Authors:  Sarah R Pickens; Michael V Volin; Arthur M Mandelin; Jay K Kolls; Richard M Pope; Shiva Shahrara
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

Review 2.  Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.

Authors:  James A McCubrey; Stephen L Abrams; Kristin Stadelman; William H Chappell; Michelle Lahair; Richard A Ferland; Linda S Steelman
Journal:  Adv Enzyme Regul       Date:  2009-11-04

3.  c-Myc plays a key role in TADs-induced apoptosis and cell cycle arrest in human hepatocellular carcinoma cells.

Authors:  Dongdong Zhang; Junpeng Qi; Rui Liu; Bingling Dai; Weina Ma; Yingzhuan Zhan; Yanmin Zhang
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

4.  Oroxylin A inhibits angiogenesis through blocking vascular endothelial growth factor-induced KDR/Flk-1 phosphorylation.

Authors:  Ying Gao; Na Lu; Yun Ling; Yan Chen; Ling Wang; Qing Zhao; Qi Qi; Wei Liu; Haiwei Zhang; Qidong You; Qinglong Guo
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-04       Impact factor: 4.553

5.  Bp5250 inhibits vascular endothelial growth factor-induced angiogenesis and HIF-1α expression on endothelial cells.

Authors:  Kuan-Ting Lin; Jin-Cherng Lien; Ching-Hu Chung; Sheng-Chu Kuo; Tur-Fu Huang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-25       Impact factor: 3.000

6.  Long non-coding RNA HOTAIR enhances angiogenesis by induction of VEGFA expression in glioma cells and transmission to endothelial cells via glioma cell derived-extracellular vesicles.

Authors:  Xin Ma; Zhaohui Li; Ting Li; Linwensi Zhu; Zhenshengnan Li; Nan Tian
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

7.  Myricetin inhibits UVB-induced angiogenesis by regulating PI-3 kinase in vivo.

Authors:  Sung Keun Jung; Ki Won Lee; Sanguine Byun; Eun Jung Lee; Jong-Eun Kim; Ann M Bode; Zigang Dong; Hyong Joo Lee
Journal:  Carcinogenesis       Date:  2009-12-11       Impact factor: 4.944

8.  Altered hypoxia-inducible factor-1 alpha expression levels correlate with coronary vessel anomalies.

Authors:  Jamie Wikenheiser; Julie A Wolfram; Madhusudhana Gargesha; Ke Yang; Ganga Karunamuni; David L Wilson; Gregg L Semenza; Faton Agani; Steven A Fisher; Nicole Ward; Michiko Watanabe
Journal:  Dev Dyn       Date:  2009-10       Impact factor: 3.780

9.  Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells.

Authors:  Haitao Luo; Gary O Rankin; Lingzhi Liu; Matthew K Daddysman; Bing-Hua Jiang; Yi Charlie Chen
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

10.  Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cells.

Authors:  Martin Michaelis; Denise Klassert; Susanne Barth; Tatyana Suhan; Rainer Breitling; Bernd Mayer; Nora Hinsch; Hans W Doerr; Jaroslav Cinatl; Jindrich Cinatl
Journal:  Mol Cancer       Date:  2009-09-29       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.